Zacks Research Issues Optimistic Estimate for PAHC Earnings

Phibro Animal Health Co. (NASDAQ:PAHC) – Stock analysts at Zacks Research lifted their Q2 2025 earnings per share estimates for Phibro Animal Health in a research report issued on Wednesday, January 15th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $0.36 for the quarter, up from their previous estimate of $0.35. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.62 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q4 2025 earnings at $0.43 EPS, FY2025 earnings at $1.49 EPS, Q2 2026 earnings at $0.50 EPS, Q4 2026 earnings at $0.51 EPS, FY2026 earnings at $1.67 EPS and Q2 2027 earnings at $0.54 EPS.

A number of other analysts have also weighed in on the stock. Morgan Stanley raised their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Barclays raised their price target on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 12th. Finally, StockNews.com cut shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Sunday, January 12th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $20.50.

Phibro Animal Health Price Performance

Phibro Animal Health stock opened at $20.93 on Friday. Phibro Animal Health has a 12-month low of $10.03 and a 12-month high of $25.98. The company has a current ratio of 3.23, a quick ratio of 1.69 and a debt-to-equity ratio of 1.81. The firm has a 50-day moving average price of $22.56 and a 200-day moving average price of $21.17. The firm has a market capitalization of $847.67 million, a PE ratio of 48.68, a price-to-earnings-growth ratio of 0.52 and a beta of 0.53.

Institutional Investors Weigh In On Phibro Animal Health

Hedge funds have recently made changes to their positions in the stock. nVerses Capital LLC purchased a new stake in shares of Phibro Animal Health during the third quarter valued at about $70,000. Quantbot Technologies LP bought a new position in shares of Phibro Animal Health during the 3rd quarter worth approximately $70,000. China Universal Asset Management Co. Ltd. lifted its position in Phibro Animal Health by 63.7% during the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after acquiring an additional 1,522 shares during the last quarter. CWM LLC boosted its stake in Phibro Animal Health by 190.8% in the third quarter. CWM LLC now owns 6,363 shares of the company’s stock valued at $143,000 after acquiring an additional 4,175 shares in the last quarter. Finally, Algert Global LLC purchased a new position in Phibro Animal Health in the second quarter worth $193,000. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, November 27th. This represents a $0.48 annualized dividend and a dividend yield of 2.29%. Phibro Animal Health’s dividend payout ratio is currently 111.63%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.